AUTHOR=Zare Zahra , Hosseinzadeh Mahdieh , Sharuni Fatemeh , Rohani Fatemeh Sadat , Hojjat Hashem , Rahimpour Shahab , Madadizadeh Farzan , Zavar Reza Javad , Wong Alexei , Nadjarzadeh Azadeh 

TITLE=The effect of the dietary approaches to stop hypertension diet on total antioxidant capacity, superoxide dismutase, catalase, and body composition in patients with non-alcoholic fatty liver disease: a randomized controlled trial

JOURNAL=Frontiers in Nutrition

VOLUME=10

YEAR=2023

URL=https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2023.1163516

DOI=10.3389/fnut.2023.1163516

ISSN=2296-861X

ABSTRACT=<sec><title>Aim</title><p>Non-alcoholic fatty liver disease (NAFLD) is a condition characterized by the accumulation of fat in the liver without excessive alcohol consumption. Lifestyle modifications, such as adopting a healthy diet, represent the standard treatment for NAFLD. However, the impact of the Dietary Approaches to Stop Hypertension (DASH) diet on oxidative stress biomarkers in patients with NAFLD remains unclear. Therefore, this study aimed to determine the effect of the DASH diet on total antioxidant capacity (TAC), catalase (CAT), superoxide dismutase (SOD) levels, and body composition in overweight and obese patients with NAFLD.</p></sec><sec><title>Methods</title><p>A total of 70 overweight and obese patients aged 1870 years were randomly assigned to either the intervention (DASH diet, <italic>n</italic> = 35) or the control group (control diet, <italic>n</italic> = 35) for 12 weeks, with both groups following a calorie-restricted diet.</p></sec><sec><title>Results</title><p>The mean age of participants was 43.1 ± 8.1 years in the DASH group and 45.1 ± 8.6 years in the control group. At the end of the study, a significant difference was observed in the mean TAC and SOD levels between the two groups (<italic>p</italic> = 0.02). After adjusting for potential confounding factors, such as age, sex, diabetes, smoking, physical activity, and baseline values, the DASH diet maintained its significant effects on TAC and SOD compared to the control diet (<italic>p</italic> = 0.03). However, there were no significant differences in CAT levels between the two groups. Moreover, a significant reduction in visceral fat (<italic>p</italic> = 0.01) and a marginally significant decrease in BMI (<italic>p</italic> = 0.06) were observed in the DASH group compared to the control group after adjusting for potential confounders.</p></sec><sec><title>Conclusion</title><p>In conclusion, our study showed that following the DASH diet for 12 weeks in overweight and obese patients with NAFLD has beneficial effects on TAC, SOD, and visceral fat. These findings support the use of the DASH diet as a potential therapeutic intervention for the improvement of oxidative biomarkers in patients with NAFLD.</p></sec><sec><title>Clinical trial registration</title><p><ext-link ext-link-type="uri" xlink:href="https://www.irct.ir/" xmlns:xlink="http://www.w3.org/1999/xlink">www.irct.ir/</ext-link>, identifier IRCT20170117032026N3.</p></sec>